The Good News About Bulk Sequence Applications
The good news about bulk sequence applications is that every sequence that is disclosed in the application becomes part of the public domain when the bulk sequence application publishes. This means that all of the sequences, whether they are claimed or simply disclosed in the specification, can no longer be patented by anyone else in that particular jurisdiction, unless they are already the subject of an earlier filed patent.
Another factor to consider is that for each bulk sequence application, the applicant may file a number of divisional applications in order to claim additional nucleotide sequences. Although, this strategy is likely to be cost prohibitive to most patent seekers. Therefore, a patent family stemming from a bulk sequence application is most likely to result in only a handful of claimed nucleotide sequences.
There are no comments.